ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

BIIB Biogen Inc

208.50
6.04 (2.98%)
2024年4月27日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Biogen Inc BIIB NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
6.04 2.98% 208.50 09:00:00
始値 安値 高値 終値 前日終値
201.22 199.10 210.83 208.90 202.46
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/0108:30PRNUSEisai Completes Submission of LEQEMBI® (lecanemab-irmb)..
2024/3/0621:30GLOBENew Biomarker Data Add Further Evidence Supporting the..
2024/3/0506:15GLOBEBiogen Highlights New Data at the International Conference..
2024/2/2709:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2321:00GLOBEBiogen’s QALSODY® (tofersen), the First Therapy to Treat..
2024/2/2300:12EDGAR2Form 144 - Report of proposed sale of securities
2024/2/2211:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2211:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2211:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2211:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2211:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2211:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2211:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2200:24EDGAR2Form 144 - Report of proposed sale of securities
2024/2/2111:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1408:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1408:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1408:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1408:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1408:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1408:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1407:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1321:07EDGAR2Form 8-K - Current report
2024/2/1309:11EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1309:07EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1306:06GLOBEBiogen Received European Commission Approval for SKYCLARYS®..
2024/2/1301:10EDGAR2Form 144 - Report of proposed sale of securities
2024/2/1010:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1010:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1010:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1010:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1010:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1010:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1010:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1010:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1009:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1009:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0608:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0300:44EDGAR2Form 144 - Report of proposed sale of securities
2024/2/0107:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0107:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0107:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0107:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0107:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0107:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0107:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2504:27EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2023/12/1921:30GLOBECentralized Marketing Authorizations of Generic Versions of..
2023/12/1523:05GLOBECHMP Issues Positive Opinion for Biogen’s SKYCLARYS®..
2023/12/1420:30GLOBEZURZUVAE™ (zuranolone) CIV, a Landmark Oral Treatment for..

最近閲覧した銘柄

Delayed Upgrade Clock